Skip to main content
. 2016 Oct 14;33(11):1983–2000. doi: 10.1007/s12325-016-0419-1

Table 3.

Chemotherapy history (all-patients set)

Hematological malignancies (N = 48) Breast cancer (N = 233) Other solid tumors (N = 105) Total (N = 386)
Prior chemotherapy, n (%) 32 (66.7) 70 (30.0) 62 (59.0) 164 (42.5)
Number of prior chemotherapy regimens, n (%) 0 3 (6.3) 2 (0.9) 1 (1.0) 6 (1.6)
1 14 (29.2) 43 (18.5) 33 (31.4) 90 (23.3)
2 4 (8.3) 6 (2.6) 12 (11.4) 22 (5.7)
3 4 (8.3) 7 (3.0) 8 (7.6) 19 (4.9)
4 2 (4.2) 3 (1.3) 1 (1.0) 6 (1.6)
5 1 (2.1) 1 (0.4) 1 (1.0) 3 (0.8)
6 0 3 (1.3) 2 (1.9) 5 (1.3)
8 1 (2.1) 2 (0.9) 0 3 (0.8)
9 1 (2.1) 1 (0.4) 0 2 (0.5)
60 0 0 1 (1.0) 1 (0.3)
Not recorded 18 165 46 229